Martek Says “Momentum” For DHA Ingredient Drives Sales Growth
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences' revenues grew 12 percent to $70.3 million in its fiscal 2007 first quarter from the prior-year quarter as 11 products containing its DHA ingredient were launched, the Columbia, Md.-based firm said March 7
You may also be interested in...
Martek Expects Growth With Restructuring Plan, Including Layoffs
Martek Biosciences continues to push its growth with a new restructuring plan that should make it leaner and meaner, according to an Oct. 26 release
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.